McKinsey and OxyContin
I had no idea bout this story because normally don't pay attention but thanks to Victor Cheng I learned about. Can't post links but google New York Times article from 2021/02/ opiods settlement or any other source.
Cheng describes it pretty well actually and denounces McKinsey. What struck me is that he is probably right because McK run the analysis and knew the possible outcomes but still decided to accept the business knowing they gamble on human lifes even after Pardue pleaded guilty in court. Plus McK haven't admitted wrondoing, just gave away cash as a result of the settlement.
I am not going to apply for a job with McK(1st year at target school). Yeah I know it is cool etc but brand name will be affected and I dont want to be associated with it. What is your takeaway? Will it harm the reputation in the long run in the eyes of MBA adcoms and clients in part due to social justice trend?